| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 79.25B | 78.62B | 73.42B | 78.50B | 71.75B | 65.33B |
| Gross Profit | 8.45B | 8.70B | 8.11B | 8.53B | 7.78B | 6.86B |
| EBITDA | 7.03B | 7.52B | 7.06B | 7.81B | 7.66B | 6.79B |
| Net Income | 6.82B | 4.91B | 3.73B | 3.76B | 5.26B | 2.75B |
Balance Sheet | ||||||
| Total Assets | 117.57B | 117.45B | 112.77B | 115.83B | 108.99B | 104.40B |
| Cash, Cash Equivalents and Short-Term Investments | 13.32B | 11.83B | 12.48B | 25.27B | 21.23B | 20.29B |
| Total Debt | 27.87B | 30.33B | 27.41B | 37.87B | 36.31B | 38.63B |
| Total Liabilities | 50.70B | 52.11B | 50.14B | 57.96B | 55.33B | 56.14B |
| Stockholders Equity | 65.86B | 64.38B | 61.74B | 57.07B | 53.34B | 47.91B |
Cash Flow | ||||||
| Free Cash Flow | 3.09B | 212.00M | -680.00M | 5.51B | 5.38B | 3.68B |
| Operating Cash Flow | 6.81B | 6.35B | 5.83B | 6.73B | 6.03B | 6.95B |
| Investing Cash Flow | 372.00M | -6.01B | -6.94B | -2.74B | -868.00M | -3.29B |
| Financing Cash Flow | -6.33B | -1.41B | -11.69B | -2.04B | -3.69B | 1.36B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | ¥81.73B | 6.51 | ― | 3.48% | 4.17% | 24.54% | |
73 Outperform | ¥15.23B | 7.26 | ― | 3.85% | 4.96% | 38.47% | |
68 Neutral | ¥515.17B | 11.01 | 13.93% | 2.81% | 8.22% | 48.07% | |
68 Neutral | ¥82.26B | 9.20 | ― | 3.63% | 2.67% | 18.02% | |
67 Neutral | ¥322.37B | 19.07 | ― | 2.94% | 4.50% | 82.34% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
57 Neutral | ¥320.82B | 20.24 | ― | 1.28% | 8.11% | -9.27% |